Treatment with Adenosine Diphosphate Receptor Inhibitors-Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) study design: Expanding the paradigm of longitudinal observational research

American Heart Journal

Volumn 162, Issue 5, 2011, Pages 844-851

  Chin, Chee Tang ^a,b   Wang, Tracy Y ^b   Anstrom, Kevin J ^b   Zhu, Baojin ^c   Maa, Jen Fue ^d   Messenger, John C ^e   Ryan, Kelley A ^b   Davidson Ray, Linda ^b   Zettler, Marjorie ^c   Effron, Mark B ^c   Mark, Daniel B ^b   Peterson, Eric D ^b  

^a DEPARTMENT OF CARDIOLOGY   (Singapore)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c Lilly USA   (United States)

^d DAIICHI SANKYO INC   (United States)

^e UNIVERSITY OF COLORADO HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RECEPTOR INHIBITOR; CARDIOVASCULAR AGENT; TICAGRELOR; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ARTICLE; BLEEDING; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); FOLLOW UP; HEALTH CARE DELIVERY; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL DISCHARGE; HUMAN; METHODOLOGY; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STENT THROMBOSIS; STROKE; THROMBOCYTE FUNCTION; TREATMENT OUTCOME; TREATMENT WITH ADENOSINE DIPHOSPHATE RECEPTOR INHIBITORS LONGITUDINAL ASSESSMENT OF TREATMENT PATTERNS AND EVENTS AFTER ACUTE CORONARY SYNDROME STUDY;

ACUTE CORONARY SYNDROME; HUMANS; LONGITUDINAL STUDIES; PATIENT SELECTION; PLATELET AGGREGATION INHIBITORS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; RESEARCH DESIGN;

EID: 81255201369     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.08.021     Document Type: Article

References (25)

1. C. Patrono, F. Bachmann, and C. Baigent Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology Eur Heart J 25 2004 166 181 (Pubitemid 38112156)
2. S. Yusuf, F. Zhao, and S.R. Mehta Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502 (Pubitemid 32758501)
3. S.R. Mehta, S. Yusuf, and R.J. Peters Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533 (Pubitemid 32772726)
4. J.L. Anderson, C.D. Adams, and E.M. Antman ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine Circulation 116 2007 e148 304
5. J.P. Bassand, C.W. Hamm, and D. Ardissino Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes Eur Heart J 28 2007 1598 1660
6. E.M. Antman, M. Hand, and P.W. Armstrong 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 51 2008 210 247
7. R.S. Wright, J.L. Anderson, and C.D. Adams 2011 ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 57 2011 1920 1959
8. J.L. Mega, S.L. Close, and S.D. Wiviott Cytochrome p-450 polymorphisms and response to clopidogrel N Engl J Med 360 2009 354 362
9. P.M. Ho, T.M. Maddox, and L. Wang Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome JAMA 301 2009 937 944
10. S.D. Wiviott, E. Braunwald, and C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
11. J.A. Jakubowski, K.J. Winters, and H. Naganuma Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile Cardiovasc Drug Rev 25 2007 357 374 (Pubitemid 350233359)
12. D.A. Morrow, S.D. Wiviott, and H.D. White Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction Circulation 119 2009 2758 2764
13. B.R. Shah, J. Drozda, and E.D. Peterson Leveraging observational registries to inform comparative effectiveness research Am Heart J 160 2010 8 15
14. R.G. Brindis, S. Fitzgerald, and H.V. Anderson The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR): building a national clinical data repository J Am Coll Cardiol 37 2001 2240 2245
15. D.E. Morisky, A. Ang, and M. Krousel-Wood Predictive validity of a medication adherence measure in an outpatient setting J Clin Hypertens (Greenwich) 10 2008 348 354
16. J.J. Ellis, K.A. Eagle, and E.M. Kline-Rogers Validation of the EQ-5D in patients with a history of acute coronary syndrome Curr Med Res Opin 21 2005 1209 1216 (Pubitemid 41140724)
17. L. Bonello, U.S. Tantry, and R. Marcucci Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate J Am Coll Cardiol 56 2010 919 933
18. M.J. Price, P.B. Berger, and P.S. Tierstein Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial JAMA 305 2011 1097 1105
19. 12510(k) Summary Available at: http://www.accessdata.fda.gov/cdrh-docs/pdf5/K051231.pdf Published August 5, 2005. Last accessed March 7, 2011
20. L. Mauri, T.S. Silbaugh, and R.E. Wolf Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts Circulation 118 2008 1817 1827
21. E. Zerhouni Medicine. The NIH roadmap Science 302 2003 63 72
22. R.M. Califf Issues facing clinical trials of the future J Intern Med 254 2003 426 433 (Pubitemid 37346625)
23. H.M. Krumholz, A.R. Merrill, and E.M. Schone Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission Circ Cardiovasc Qual Outcomes 2 2009 407 413
24. United States Department of Health and Human Services. Hospital Compare web site Available at: http://www.hospitalcompare.hhs.gov Updated: December 11, 2010. Last accessed March 7, 2011
25. Investigators The GUSTO An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 1993 673 682